REGENXBIO, Inc. (RGNX)
8.14
-0.27
(-3.21%)
USD |
NASDAQ |
Feb 20, 16:00
8.14
0.00 (0.00%)
After-Hours: 20:00
REGENXBIO SG&A Expense (Quarterly) : 20.25M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 91.89M |
| Omeros Corp. | 10.40M |
| AbbVie, Inc. | 3.895B |
| CytomX Therapeutics, Inc. | 6.427M |
| Krystal Biotech, Inc. | 41.45M |